Company intelligence / Profile preview
Epimmune Inc.
San Diego, California, United Statesace-canine.com ↗
- Ownership
- Private
- Employees
- ~55
- Development stage
- Phase 1
01
Overview
Epimmune developed peptide-based immunotherapies targeting cancer and infectious diseases. Its lead program EP2101 reached Phase II for non-small cell lung cancer before the company merged into IDM Pharma. The company also led a major NIH-backed effort to develop an HIV vaccine using its proprietary epitope technologies. Most clinical assets were discontinued or outlicensed following mergers/acquisitions.
- Therapeutic areas
- OncologyCardiovascularInfectious Diseases
- Modalities
- Peptide-based vaccines/epitopesImmunostimulantsSmall molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Rhein Biotech – research agreement combining PADRE® technology with Rhein’s platformsBavarian Nordic – partnered on NIH-funded HIV vaccine projectSRI International & Althea Technologies – collaborators on HIV vaccine contract
Beyond the preview
Go deeper on Epimmune Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epimmune Inc..